Leaders in



Valencia Technologies is a neuromodulation company transforming the standard of care for bladder dysfunction.

Market Innovation

The company’s implantable neuromodulation technology is reshaping the delivery of long term therapy for bladder control. eCoin® is a tibial implant for Urge Urinary Incontinence (UUI). The coin sized neurostimulator is placed under the skin near the ankle during a consistent, minimally invasive procedure using only local anaesthetic.

The eCoin® device provides automatic stimulation on the tibial nerve via a forgiving dome shaped field. eCoin eliminates lead wires optimized by precise placement, patient management of the device with external remotes, recharge requirements, general anesthesia or sedation with placement.


The company is headquartered in Valencia, California and is backed by leaders in healthcare technology and neurostimulation therapy.

ABOUT eCoin®

Minimally Invasive

• Effective Leadless Neurostimulation Therapy for UUI

Drug Free Relief for People with Urge Urinary Incontinence

® is FDA Approved – Important Safety Information

Learn More


Jeff Greiner
Chairman of the Board

Founder of Valencia Technologies.  Previously was long-term CEO of Advanced Bionics (AB).  Al Mann founded AB and appointed Jeff as CEO to lead a team of seven engineers and scientists.  Led AB from Phase 1 clinical trials to over $300M in annual revenue; 2,500 employees.  Sold the business to Boston Scientific and Sonova for gross proceeds of ~$3 billion.  LLM from George Washington, JD from UCLA and BS in Economics from the United States Air Force Academy.

Jerry Schloffman
Chief Executive Officer (Interim) / Chief Commercial Officer

24 years of corporate experience in implantable medical devices. Prior President of Sycle, a leading SAAS practice management solution for audiologist and hearing aid retailers. Formerly Chief of Clinical Operations at Valencia…

Russ Ramanayake
Vice President of Finance

More than 25 years of corporate experience in medical devices including M&A, Divestures and IPOs, Previous Corporate Controller for Second Sight Medical products and played a key role in successful completion of IPO in 2014…

Erik Styacich
Vice President of Sales

17+ years of experience in the Med Tech industry, with the majority of that time spent in Urology and Neuromodulation. Prior to VTC, Erik led sales teams in the Interventional Urology business unit (Urolift) at Teleflex, Nuvectra Medical…

Ann Decker
Vice President of Reimbursement and Health Policy

30 years in health care industry with over 25 in medical device reimbursement and health policy strategy.  Former VP of Reimbursement & Health Policy at Teleflex.

Nicole Barber
Sr. Director of Regulatory & Clinical Affairs

19 years of experience in implantable medical devices. Former VP of Regulatory Affairs and Compliance Officer at CeloNova BioSciences and previous experience in Regulatory Affairs at Genentech, Osseon…


Valencia Technologies is led by neuromodulation pioneers who have successfully scaled biotech companies from infancy to $300M in annual revenue.

Leaders in

The business and technical leadership of Valencia is unsurpassed within the field of neuromodulation.

Read More


Be part of a highly skilled team that is focus on high growth and market disruption.

Read More


Join a collaborative, cross-functional organization that
delivers outstanding results with laser focus on patient outcomes and physician satisfaction.

Read More


Drop us a line to connect and learn more about Valencia Technologies.


Follow Our Social Media

Join us on your favorite social platform.


28464 Westinghouse Place
Valencia, CA 91355
United States

Website: valenciatechnologies.com

Corporate Office: (661) 775-1414

Administration Office: (661) 505-7264

Customer Service Help Desk: (833)-326-4687

Go to Top